Inventor · disambiguated record
Stuart Thomas Onions
Also filed as: ONIONS STUART · ONIONS STUART THOMAS
65 granted patents·9 pending applications·655 citations·filing 2007–2023
99Inventor score
Top patents by PatentIndex Score
74 records- 0197US9624196B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2016·Granted Apr 18, 2017·15 cites·5 claims
- 0297US9108950B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2012·Granted Aug 18, 2015·38 cites·13 claims
- 0396US10858345B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2020·Granted Dec 8, 2020·3 cites·20 claims
- 0496US9447076B2Inhibitor of p38 map kinaseRESPIVERT LTD·Filed 2015·Granted Sep 20, 2016·16 cites·18 claims
- 0596US8642773B2P38MAP kinase inhibitorITO KAZUHIRO·Filed 2010·Granted Feb 4, 2014·44 cites·4 claims
- 0696US8293771B2p38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 23, 2012·49 cites·9 claims
- 0796US8293748B2p38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 23, 2012·47 cites·19 claims
- 0895US9732098B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativeHUNT SIMON FRASER·Filed 2015·Granted Aug 15, 2017·32 cites·13 claims
- 0995US8618140B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2012·Granted Dec 31, 2013·41 cites·20 claims
- 1095US8299073B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 30, 2012·50 cites·19 claims
- 1195US8299074B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 30, 2012·48 cites·17 claims
- 1294US10106531B2Compound useful to treat mycosesPULMOCIDE LTD·Filed 2015·Granted Oct 23, 2018·10 cites·34 claims
- 1394US8975285B2P38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Mar 10, 2015·26 cites·3 claims
- 1493US11661415B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2020·Granted May 30, 2023·2 cites·20 claims
- 1593US10662179B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2019·Granted May 26, 2020·3 cites·20 claims
- 1693US10344022B2Compound useful to treat mycosesPULMOCIDE LTD·Filed 2018·Granted Jul 9, 2019·7 cites·19 claims
- 1792US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 1892US10738032B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2019·Granted Aug 11, 2020·3 cites·24 claims
- 1992US9475796B21-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2012·Granted Oct 25, 2016·12 cites·14 claims
- 2092US9249125B2Pyrazole derivatives as p38 MAP inhibitorsRESPIVERT LTD·Filed 2013·Granted Feb 2, 2016·30 cites·12 claims
- 2192US9024041B2P38 MAP kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2011·Granted May 5, 2015·27 cites·28 claims
- 2291US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 2391US10266519B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Apr 23, 2019·6 cites·11 claims
- 2491US8933228B2Respiratory formulations and compounds for use thereinMURRAY PETER JOHN·Filed 2011·Granted Jan 13, 2015·40 cites·35 claims
- 2590US10450304B2Compound useful to treat mycosesPULMOCIDE LTD·Filed 2019·Granted Oct 22, 2019·4 cites·10 claims
- 2689US9724347B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitorsRESPIVERT LTD·Filed 2016·Granted Aug 8, 2017·5 cites·17 claims
- 2788US9850231B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Dec 26, 2017·5 cites·8 claims
- 2887US12269814B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2023·Granted Apr 8, 2025·0 cites·20 claims
- 2987US9227977B2Phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Jan 5, 2016·4 cites·7 claims
- 3087US8217050B2Adenine derivative as inhibitors of HSP90 for the treatment of cancerMOFFAT DAVID FESTUS CHARLES·Filed 2007·Granted Jul 10, 2012·15 cites·14 claims
- 3186US10238658B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2018·Granted Mar 26, 2019·3 cites·19 claims
- 3285US9242960B2P38MAP kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Jan 26, 2016·6 cites·6 claims
- 3384US9260410B2P38 MAP kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2011·Granted Feb 16, 2016·7 cites·10 claims
- 3484US8003695B2IKK-beta serine-threonine protein kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2007·Granted Aug 23, 2011·9 cites·11 claims
- 3583US10294216B2Pyrazolyl ureas as kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted May 21, 2019·1 cites·13 claims
- 3683US10189863B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativesPULMOCIDE LTD·Filed 2015·Granted Jan 29, 2019·3 cites·24 claims
- 3783US9993478B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitorsRESPIVERT LTD·Filed 2017·Granted Jun 12, 2018·2 cites·19 claims
- 3883US9701670B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Jul 11, 2017·10 cites·18 claims
- 3982US10035810B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativePULMOCIDE LTD·Filed 2018·Granted Jul 31, 2018·2 cites·7 claims
- 4082US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 4181US11613542B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 28, 2023·2 cites·32 claims
- 4281US9926335B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativeHUNT SIMON FRASER·Filed 2017·Granted Mar 27, 2018·2 cites·4 claims
- 4380US11542255B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jan 3, 2023·2 cites·24 claims
- 4480US2024343711A11-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitorsRESPIVERT LTD·Filed 2023·Application pending·0 cites
- 4579US8106091B2Inhibitors of IKK-beta serine-threonine protein kinaseMOFFAT DAVID CHARLES FESTUS·Filed 2007·Granted Jan 31, 2012·9 cites·15 claims
- 4676US11634406B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2020·Granted Apr 25, 2023·0 cites·10 claims
- 4776US11142515B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2019·Granted Oct 12, 2021·0 cites·9 claims
- 4876US9884845B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Feb 6, 2018·1 cites·17 claims
- 4974US10118920B2Isoxazolyl substituted benzimidazolesCELLCENTRIC LTD·Filed 2016·Granted Nov 6, 2018·2 cites·16 claims
- 5072US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →